- Investing Ideas
- /
- Danish Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Danish Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
2
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
2 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
NOVO B | DKK 638.80 | 2.6% | -12.4% | DKK 2.8t | DKK 898.09 | PE29.8x | E13.1% | 1.5% | ||
ALK B | DKK 162.70 | 3.6% | 57.8% | DKK 36.0b | DKK 179.20 | PE45.8x | E27.3% | 0% |
Page 1 of 1